Skip to main content

Table 2 Logistic regression models examining associations of quintile of neighborhood deprivation with the odds of metabolic syndrome components and inflammation (higher quintiles indicate less deprivation)

From: Associations of neighborhood area level deprivation with the metabolic syndrome and inflammation among middle- and older- age adults

Variable

Quintile 1

Quintile 2

Quintile 3

Quintile 4

Quintile 5

Black Adults

     

Obese (BMI > =30)

1.27 (1.02,1.58)

1.25 (1.01,1.57)

1.21 (0.96,1.51)

1.07 (0.85,1.35)

Reference

High waist circumference (>102 cm (>40 in) for men; > 88 cm (>35 in) for women

1.23 (0.98,1.55)

1.25 (0.99,1.57)

1.25 (0.99,1.58)

1.05 (0.83,1.33)

Reference

High triglycerides (>150 mg/dL)

1.30 (0.95,1.77)

1.27 (0.93,1.74)

1.28 (0.93, 1.75)

1.06 (0.76,1.48)

Reference

Low HDL (for men <40 mg/dL, for women < 50 mg/dL or on lipid lowering medication)

1.38 (1.09,1.76)

1.27 (1.00,1.61)

1.28 (1.00,1.63)

1.07 (0.83,1.38)

Reference

Blood pressure > 130/> 85 mm Hg or on antihypertensive medications

1.34 (1.07,1.68)

1.32 (1.05,1.66)

1.20 (0.95,1.51)

1.09 (0.86,1.38)

Reference

High fasting glucose > 110 mg/dL or on antidiabetic medications

1.41 (1.10,1.79)

1.41 (1.11,1.80)

1.29 (1.01,1.65)

1.12 (0.87,1.45)

Reference

Metabolic syndrome

1.19 (0.91,1.57)

1.19 (0.90,1.57)

1.18 (0.89,1.57)

0.96 (0.71,1.29)

Reference

Inflammation (CRP ≥ 3 mg/L)

1.36 (1.09,1.70)

1.23 (0.98,1.54)

1.21 (0.97,1.52)

1.17 (0.93,1.48)

Reference

Metabolic syndrome with inflammation

1.52 (1.20,1.92)

1.39 (1.10,1.77)

1.36 (1.07,1.74)

1.13 (0.88,1.45)

Reference

White Adults

     

Obese (BMI > =30)

1.69 (1.44,1.98)

1.69 (1.48,1.92)

1.40 (1.24,1.58)

1.21 (1.08,1.36)

Reference

High waist circumference (>102 cm (>40 in) for men; > 88 cm (>35 in) for women

1.58 (1.36,1.84)

1.59 (1.40,1.80)

1.44 (1.29,1.61)

1.29 (1.16,1.44)

Reference

High triglycerides (>150 mg/dL)

1.20 (1.03,1.41)

1.20 (1.05,1.36)

1.27 (1.13,1.42)

1.13 (1.01,1.27)

Reference

Low HDL (for men <40 mg/dL, for women < 50 mg/dL or on lipid lowering medication)

1.44 (1.23,1.67)

1.46 (1.28,1.67)

1.41 (1.26,1.59)

1.37 (1.23,1.53)

Reference

Blood pressure > 130/> 85 mm Hg or on antihypertensive medications

1.13 (0.97,1.31)

1.20 (1.06,1.36)

1.14 (1.02,1.28)

1.14 (1.03,1.26)

Reference

High fasting glucose > 110 mg/dL or on antidiabetic medications

1.58 (1.32,1.89)

1.43 (1.23,1.67)

1.32 (1.15,1.52)

1.07 (0.93,1.22)

Reference

Metabolic syndrome

1.78 (1.50,2.12)

1.62 (1.39,1.88)

1.56 (1.36,1.79)

1.38 (1.21,1.57)

Reference

Inflammation (CRP≥3 mg/L)

1.25 (1.07,1.45)

1.37 (1.21,1.56)

1.19 (1.06,1.35)

1.17 (1.05,1.31)

Reference

Metabolic syndrome with inflammation

1.65 (1.41,1.93)

1.67 (1.46,1.91)

1.55 (1.37,1.75)

1.37 (1.22,1.54)

Reference

  1. Model adjusted for age, sex, region, smoking, individual level education and income.
  2. N = 18,779.